GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » LifeStance Health Group Inc (NAS:LFST) » Definitions » Debt-to-EBITDA

LifeStance Health Group (LifeStance Health Group) Debt-to-EBITDA : -12.02 (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is LifeStance Health Group Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

LifeStance Health Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $46 Mil. LifeStance Health Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $462 Mil. LifeStance Health Group's annualized EBITDA for the quarter that ended in Dec. 2023 was $-42 Mil. LifeStance Health Group's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was -12.02.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for LifeStance Health Group's Debt-to-EBITDA or its related term are showing as below:

LFST' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -4.84   Med: -1.99   Max: 4.09
Current: -4.84

During the past 5 years, the highest Debt-to-EBITDA Ratio of LifeStance Health Group was 4.09. The lowest was -4.84. And the median was -1.99.

LFST's Debt-to-EBITDA is ranked worse than
100% of 421 companies
in the Healthcare Providers & Services industry
Industry Median: 2.58 vs LFST: -4.84

LifeStance Health Group Debt-to-EBITDA Historical Data

The historical data trend for LifeStance Health Group's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LifeStance Health Group Debt-to-EBITDA Chart

LifeStance Health Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-EBITDA
4.09 N/A -0.66 -3.32 -4.84

LifeStance Health Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.02 -8.40 -4.55 -2.30 -12.02

Competitive Comparison of LifeStance Health Group's Debt-to-EBITDA

For the Medical Care Facilities subindustry, LifeStance Health Group's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LifeStance Health Group's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where LifeStance Health Group's Debt-to-EBITDA falls into.



LifeStance Health Group Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

LifeStance Health Group's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(46.475 + 461.642) / -104.926
=-4.84

LifeStance Health Group's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(46.475 + 461.642) / -42.268
=-12.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2023) EBITDA data.


LifeStance Health Group  (NAS:LFST) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


LifeStance Health Group Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of LifeStance Health Group's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


LifeStance Health Group (LifeStance Health Group) Business Description

Traded in Other Exchanges
N/A
Address
4800 North Scottsdale Road, Suite 6000, Scottsdale, AZ, USA, AZ 85251
LifeStance Health Group Inc is a provider of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions.
Executives
Kevin Michael Mullins officer: Chief Development Officer 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Paula Cipollone officer: See Remarks 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Warren Gouk officer: Chief Administrative Officer 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Ann Varanakis officer: Chief People Officer 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Anisha Patel-dunn officer: Chief Medical Officer 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Ryan Pardo officer: See Remarks 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Danish J. Qureshi officer: Chief Growth Officer 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Pablo Pantaleoni officer: Chief Digital Officer 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
David Bourdon officer: Chief Financial Officer 6303 COWBOYS WAY, SUITE 350, FRISCO TX 75034
Kenneth A Burdick director, officer: Chief Executive Officer 6705 ROCKLEDGE DR, SUITE 900, BETHESDA MD 20817
Felicia Gorcyca officer: Chief People Officer 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Michael K. Lester director, officer: See Remarks 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Gwen H. Booth officer: Chief Operating Officer 4800 N. SCOTTSDALE ROAD, SUITE 6000, SCOTTSDALE AZ 85251
Jesse Michael Bruff officer: Chief Financial Officer 3100 HANSEN WAY, PALO ALTO CA 94304
Tpg Gp A, Llc 10 percent owner 301 COMMERCE STREET, SUITE 3300, FORT WORTH TX 76102